Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Hypogammaglobulinemia
Related studies linked through entity extraction aliases.
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
- Status
- RECRUITING
- Phase
- PHASE2
Role of Antibiotic Therapy or Immunoglobulin On iNfections in hAematoLogy: Immunoglobulin Stopping or Extension
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Study to Evaluate Efficacy, Safety, and PK of XEMBIFY®+Standard Medical Treatment (SMT) Compared to Placebo+SMT to Prevent Infections in Participants With HGG and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE3
Immunoglobulin Deficiency a Treatable Cause of Fatigue in Patients With Multiple Sclerosis (MS)?
- Status
- RECRUITING
- Phase
- N/A
Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)
- Status
- COMPLETED
- Phase
- PHASE3
Immunodeficiency in MS
- Status
- UNKNOWN
- Phase
- N/A
Rituximab-Induced Hypogammaglobulinemia in Multiple Sclerosis
- Status
- UNKNOWN
- Phase
- N/A
Subcutaneous Ig in Allogeneic Stem Cell Transplant Recipients
- Status
- COMPLETED
- Phase
- NA
Personalized Immunotherapeutic for Antibiotic-resistant Infection
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Post-bypass Prophylactic IVIG in Infants and Neonates
- Status
- COMPLETED
- Phase
- NA
Investigation of Immune Disorders and Deficiencies
- Status
- UNKNOWN
- Phase
- N/A
Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)
- Status
- COMPLETED
- Phase
- PHASE3
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy, Safety and Pharmacokinetics of Gammaplex in Primary Immunodeficiency Diseases.
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Pharmacokinetic and Efficacy Study of a 10% Triple Virally Reduced Intravenous Immune Globulin Solution in Patients With Primary Immunodeficiency (Hypo- or Agammaglobulinemia)
- Status
- COMPLETED
- Phase
- PHASE2
Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Intravenous Immunoglobulin (IVIG) in Lung Transplantation
- Status
- COMPLETED
- Phase
- PHASE2